4369 — Tri Chemical Laboratories Balance Sheet
0.000.00%
- ¥126bn
- ¥116bn
- ¥11bn
Annual balance sheet for Tri Chemical Laboratories, fiscal year end - January 31st, JPY millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,618 | 1,699 | 8,034 | 11,138 | 10,497 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,056 | 3,902 | 3,896 | 4,562 | 4,035 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,147 | 7,585 | 14,386 | 18,923 | 19,009 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,916 | 7,880 | 8,014 | 8,373 | 9,269 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 15,144 | 19,868 | 28,289 | 32,116 | 31,865 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,050 | 3,290 | 3,465 | 3,676 | 2,554 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,562 | 7,266 | 6,969 | 6,239 | 4,295 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 9,582 | 12,601 | 21,320 | 25,876 | 27,570 |
Total Liabilities & Shareholders' Equity | 15,144 | 19,868 | 28,289 | 32,116 | 31,865 |
Total Common Shares Outstanding |